AgingResearch.NewsJoin free

Synergist ablation

Synergist ablation has been studied in 1 paper since 2022: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Mar 24, 2022: “Senolytic treatment rescues blunted muscle hypertrophy in old mice”.

Exposure

1 paper studies it1 findingUpdated

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Georgia Clinical and Translational Science Alliance and 7 more
  • Animals1

What did studies of Synergist ablation find?

1

Studies of Synergist ablation measured 1 outcome; the most studied are senescent cells (1 study).

Senescent cells

upin mice1

1 study

  1. Synergist ablation increases senescent cells in mice.

    “old mice had significantly more senescent cells 7 and 14 days following MOV relative to young”

    Animals7 and 14 days following MOVplantaris musclemales

    Senolytic treatment rescues blunted muscle hypertrophy in old mice

    GeroScience

More on Senescent cells

Latest

Related